← Back to Clinical Trials
Recruiting NCT07060573

NCT07060573 Effects of Oral Stimulation Performed by Parents to Improve Sucking in Neonates Hospitalized in the NICU

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07060573
Status Recruiting
Phase
Sponsor Hospital Civil de Guadalajara
Condition Premature Infant
Study Type INTERVENTIONAL
Enrollment 32 participants
Start Date 2025-07-18
Primary Completion 2027-02

Eligibility & Interventions

Sex All sexes
Min Age 34 Weeks
Max Age 36 Weeks
Study Type INTERVENTIONAL
Interventions
Parental Oral Stimulation ProtocolPhysiotherapist-led Oral Stimulation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 32 participants in total. It began in 2025-07-18 with a primary completion date of 2027-02.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This randomized clinical trial aims to evaluate the effectiveness of an oral stimulation program to improve sucking in preterm neonates hospitalized in the NICU. The study compares two groups: one receiving the intervention from a physiotherapist and the other from trained parents. The stimulation program includes 4 extraoral and 4 intraoral exercises applied once daily for 14 consecutive days. The primary outcome is improvement in the POFRAS score. Secondary outcomes include the time to exclusive oral feeding, nasogastric tube withdrawal, weight at discharge, hospital stay duration, and parental adherence. This study addresses the potential role of parent participation in neonatal rehabilitation in public hospitals with limited human resources.

Eligibility Criteria

Inclusion Criteria: * Neonates with corrected gestational age of 34 to 36 weeks * Clinically stable to receive oral stimulation * Informed consent obtained from parents or legal guardians Exclusion Criteria: * Orofacial congenital malformations * Severe neuromuscular disease * Conditions contraindicating oral feeding

Contact & Investigator

Central Contact

Nelsi Alejandra Gonzalez Gonzalez, subspecialty

✉ ngonzalez@hcg.gob.mx

📞 +5213312567344

Frequently Asked Questions

Who can join the NCT07060573 clinical trial?

This trial is open to participants of all sexes, aged 34 Weeks or older, up to 36 Weeks, studying Premature Infant. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07060573 currently recruiting?

Yes, NCT07060573 is actively recruiting participants. Contact the research team at ngonzalez@hcg.gob.mx for enrollment information.

Where is the NCT07060573 trial being conducted?

This trial is being conducted at Guadalajara, Mexico.

Who is sponsoring the NCT07060573 clinical trial?

NCT07060573 is sponsored by Hospital Civil de Guadalajara. The trial plans to enroll 32 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology